• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[疫苗:不良事件监测]

[Vaccines: adverse events surveillance].

作者信息

Abarca V Katia

机构信息

Departamento de Pediatría, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

出版信息

Rev Chilena Infectol. 2007 Feb;24(1):53-6. doi: 10.4067/s0716-10182007000100008. Epub 2007 Mar 8.

DOI:10.4067/s0716-10182007000100008
PMID:17369971
Abstract

The objective of the surveillance systems of vaccine adverse events is monitoring events temporally related to vaccination, to evaluate their causality with the vaccine and to detect events after the introduction of new vaccines. The ultimate goal of these systems is to provide the population with the best safety standard of the vaccines. The surveillance system can be passive (spontaneous reports) or active (active follow up of vaccinees); the majority of them are passive. The article gives a brief review of the most known vaccine adverse events surveillance systems, including the American Vaccine Adverse Events Report System (VAERS), the Canadian and European systems, a commentary about the Chilean one, highlighting its main advantages and also its limitations.

摘要

疫苗不良事件监测系统的目标是监测与疫苗接种在时间上相关的事件,评估这些事件与疫苗的因果关系,并在新疫苗引入后检测相关事件。这些系统的最终目标是为民众提供疫苗的最佳安全标准。监测系统可以是被动的(自发报告)或主动的(对疫苗接种者进行主动随访);其中大多数是被动的。本文简要回顾了最知名的疫苗不良事件监测系统,包括美国疫苗不良事件报告系统(VAERS)、加拿大和欧洲的系统,并对智利的系统进行了评论,突出了其主要优点和局限性。

相似文献

1
[Vaccines: adverse events surveillance].[疫苗:不良事件监测]
Rev Chilena Infectol. 2007 Feb;24(1):53-6. doi: 10.4067/s0716-10182007000100008. Epub 2007 Mar 8.
2
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.免疫接种后安全性监测:疫苗不良事件报告系统(VAERS)——美国,1991 - 2001年
MMWR Surveill Summ. 2003 Jan 24;52(1):1-24.
3
Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine.1991年至1998年脊髓灰质炎疫苗不良事件监测:灭活脊髓灰质炎疫苗随后接种口服脊髓灰质炎疫苗的序贯接种方案的影响
Pediatrics. 2001 May;107(5):E83. doi: 10.1542/peds.107.5.e83.
4
Understanding vaccine safety information from the Vaccine Adverse Event Reporting System.从疫苗不良事件报告系统中了解疫苗安全信息。
Pediatr Infect Dis J. 2004 Apr;23(4):287-94. doi: 10.1097/00006454-200404000-00002.
5
Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.1990 - 2006年向疫苗不良事件报告系统(VAERS)报告的接种疫苗后选择性终止妊娠情况。
Vaccine. 2008 May 2;26(19):2428-32. doi: 10.1016/j.vaccine.2008.02.052. Epub 2008 Mar 17.
6
Allergic reactions to Japanese encephalitis vaccine.对日本脑炎疫苗的过敏反应。
Immunol Allergy Clin North Am. 2003 Nov;23(4):665-97. doi: 10.1016/s0889-8561(03)00102-4.
7
Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS).美国婴儿接种无细胞百日咳疫苗:对疫苗不良事件报告系统(VAERS)头两年数据的评估。
Pediatrics. 2000 Oct;106(4):E51. doi: 10.1542/peds.106.4.e51.
8
Comparative safety of two recombinant hepatitis B vaccines in children: data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD).两种重组乙型肝炎疫苗在儿童中的安全性比较:来自疫苗不良事件报告系统(VAERS)和疫苗安全数据链(VSD)的数据。
J Clin Epidemiol. 1998 Jun;51(6):503-10. doi: 10.1016/s0895-4356(98)00014-6.
9
An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?对向疫苗不良事件报告系统报告的轮状病毒疫苗情况分析:仅肠套叠吗?
Pediatrics. 2004 Apr;113(4):e353-9. doi: 10.1542/peds.113.4.e353.
10
An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group.作为一种监测系统的疫苗不良事件报告系统(VAERS)概述。VAERS工作组。
Vaccine. 1999 Jul 16;17(22):2908-17. doi: 10.1016/s0264-410x(99)00132-2.